Type 1 diabetes is caused by the immune system attacking and destroying the insulin-producing cells in the pancreas. Unlike type 2 diabetes, which involves the body becoming resistant to insulin, type 1 is an autoimmune disease where the body’s own defense system turns against itself. The destruction happens gradually, sometimes over months or years, until the pancreas can no longer produce enough insulin to regulate blood sugar.
How the Immune System Destroys Insulin-Producing Cells
The pancreas contains clusters of cells called islets, and within those islets are beta cells, which are the only cells in the body that make insulin. In type 1 diabetes, a specific type of immune cell (called a CD8 T cell) mistakes proteins on the surface of beta cells for a foreign threat. These immune cells lock onto fragments of insulin that appear on the beta cell surface and launch an attack, releasing toxic enzymes that kill the cell.
The process works like a case of mistaken identity. Beta cells naturally produce insulin and package it into tiny compartments for release into the bloodstream. But some insulin molecules end up in the wrong part of the cell, where they get chopped into small fragments and displayed on the cell’s outer surface. Normally, this kind of surface display helps immune cells identify infected cells. In type 1 diabetes, the immune system treats those insulin fragments as evidence of a threat and begins systematically destroying the beta cells that display them.
This destruction doesn’t happen overnight. Most people lose beta cells gradually, and symptoms only appear once roughly 80 to 90 percent of beta cell function is gone. By the time someone is diagnosed, the autoimmune attack has typically been underway for months or even years.
The Genetic Component
Genes play a major role in determining who is vulnerable to type 1 diabetes, but they don’t act alone. The strongest genetic link involves a set of genes in the HLA region, which controls how the immune system identifies threats. Specific variants called HLA-DR3 and HLA-DR4 are found in the vast majority of people with type 1 diabetes. These variants affect how immune cells “read” the surface of beta cells, making it more likely that the immune system will misidentify insulin fragments as dangerous.
Still, more than 10% of people with type 1 diabetes don’t carry either of those high-risk gene variants. Research published in Diabetes Care identified at least 18 additional genetic risk variants that contribute to the disease in people without DR3 or DR4. Some of these variants affect how aggressively T cells respond to perceived threats, while others influence the body’s antiviral defenses or immune signaling. The picture that emerges is one of many genes, each nudging the immune system slightly closer to attacking beta cells.
Having the genetic risk doesn’t guarantee you’ll develop type 1 diabetes. It means your immune system has a predisposition that, under the right circumstances, can tip into autoimmunity.
Why Genes Alone Don’t Explain It
The clearest evidence that something beyond DNA is involved comes from studies of identical twins. If one identical twin has type 1 diabetes, the other twin develops it only about 40 to 50% of the time, with estimates ranging from 13% to 68% depending on the study and how long researchers follow the twins. If genetics were the whole story, that number would be close to 100%.
The incidence of type 1 diabetes has also been doubling roughly every 20 years across many populations. Genetic changes in a population take generations to spread, so this rapid increase points strongly toward environmental factors. Something in modern life is triggering the disease in people who are genetically susceptible, and researchers believe epigenetic changes are part of the bridge between environment and genes. Epigenetic changes are chemical modifications that sit on top of DNA and control whether specific genes are turned on or off. They can be influenced by infections, diet, toxins, and other exposures, effectively letting the environment “edit” how your genes behave without altering the genetic code itself.
Viral Infections as a Trigger
Among the environmental suspects, viruses have the strongest evidence behind them. Enteroviruses, a family of common viruses that includes the coxsackievirus, have been linked to the onset of the autoimmune process for decades. What makes the connection compelling is how these viruses interact with beta cells specifically.
Beta cells carry a receptor on their surface that enteroviruses can latch onto, giving the virus direct access to the cell. Once inside, the virus doesn’t always destroy the cell outright. Instead, beta cells can mount a partial antiviral defense that slows viral replication without eliminating the virus entirely. This creates a persistent, low-grade infection. The infected beta cell, now displaying both its own proteins and viral fragments on its surface, becomes a target for the immune system. Researchers have described this as a “Trojan horse” scenario: the virus hides inside the beta cell, and the immune response aimed at clearing the infection ends up destroying the beta cells along with it.
This doesn’t mean that catching a stomach bug will cause type 1 diabetes. In people without genetic susceptibility, the immune system clears the infection and moves on. It’s the combination of a genetically primed immune system and a viral trigger that appears to set the autoimmune cascade in motion.
Other Environmental Factors Under Investigation
Viruses aren’t the only environmental factor linked to type 1 diabetes. Early childhood diet, particularly the timing of introducing certain foods like cow’s milk or gluten, has been studied as a possible influence, though results have been mixed. Vitamin D deficiency, which is more common at higher latitudes where type 1 diabetes rates are also higher, is another area of active interest. The gut microbiome, the community of bacteria living in the intestines, has also shown differences in children who go on to develop type 1 diabetes compared to those who don’t.
None of these factors have been proven to directly cause the disease. The prevailing view is that type 1 diabetes results from a “perfect storm” of genetic vulnerability, immune system programming, and one or more environmental exposures that collectively push the immune system past a tipping point.
How Autoantibodies Track the Disease
The autoimmune attack leaves detectable traces in the blood long before symptoms appear. The immune system produces antibodies against several beta cell proteins, and these autoantibodies serve as markers of the disease process. The three most commonly tested are antibodies against an enzyme called GAD65, a protein called IA-2, and a zinc transporter known as ZnT8.
The number of autoantibodies a person carries correlates with how aggressively the immune system is attacking. People with all three markers tend to be diagnosed younger and show more severe insulin deficiency at diagnosis, with higher blood sugar levels and lower body weight. Those with a single autoantibody still show more insulin insufficiency than people with type 2 diabetes, but the effect is less pronounced. In practical terms, testing for these antibodies helps doctors distinguish type 1 from type 2 diabetes, especially in adults where the diagnosis can be ambiguous, and can identify people at risk before they develop full-blown disease.
Children and adults with two or more autoantibodies have a very high lifetime probability of progressing to clinical type 1 diabetes. This has opened the door to screening programs that can identify at-risk individuals years before symptoms begin, when intervention might slow or delay the immune attack.